Idexx Laboratories (IDXX) Other Accumulated Expenses (2010 - 2018)

Idexx Laboratories' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $65.8 million for Q1 2018.

• In Q1 2018, Other Accumulated Expenses rose 18.53% year-over-year to $65.8 million; the TTM figure through Mar 2018 stood at $65.8 million (up 18.53% YoY), while the FY2017 annual figure was $64.4 million, down 10.49% from the prior year.
• Other Accumulated Expenses for Q1 2018 stood at $65.8 million, up from $64.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $72.0 million in Q4 2016, with the low at $44.6 million in Q1 2014.
• The 5-year median for Other Accumulated Expenses is $60.2 million (2015), against an average of $58.9 million.
• The sharpest annual moves came in 2015 and 2017: Other Accumulated Expenses jumped 38.03% in 2015, then decreased 11.34% in 2017.
• Idexx Laboratories' Other Accumulated Expenses stood at $55.7 million in 2014, then advanced by 17.99% to $65.7 million in 2015, then grew by 9.62% to $72.0 million in 2016, then fell by 10.49% to $64.4 million in 2017, then gained by 2.18% to $65.8 million in 2018.
• Business Quant data shows IDXX's Other Accumulated Expenses at $65.8 million in Q1 2018, $64.4 million in Q4 2017, and $60.8 million in Q3 2017.